Evercore ISI Group Maintains Outperform on Zymeworks, Raises Price Target to $48
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Evercore ISI Group analyst Jonathan Miller maintains Zymeworks (NASDAQ:ZYME) with a Outperform and raises the price target from $33 to $48.
Evercore ISI Group analyst Jonathan Miller maintains Zymeworks (NASDAQ:ZYME) with a Outperform and raises the price target from $33 to $48.